4//SEC Filing
Rivkin Anna 4
Accession 0001562180-25-000502
CIK 0001822462other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:11 PM ET
Size
5.6 KB
Accession
0001562180-25-000502
Insider Transaction Report
Form 4
Rivkin Anna
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-22$4.37/sh+50,000$218,500→ 50,000 totalExercise: $4.37Exp: 2035-01-21→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0002035647
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:11 PM ET
- Size
- 5.6 KB